"Bioprosthesis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers.
- Heterograft Bioprosthesis
- Bioprostheses, Heterograft
- Bioprosthesis, Heterograft
- Heterograft Bioprostheses
- Xenograft Bioprosthesis
- Bioprostheses, Xenograft
- Bioprosthesis, Xenograft
- Xenograft Bioprostheses
Porcine Xenograft Bioprosthesis
- Porcine Xenograft Bioprosthesis
- Bioprostheses, Porcine Xenograft
- Bioprosthesis, Porcine Xenograft
- Porcine Xenograft Bioprostheses
- Xenograft Bioprostheses, Porcine
- Xenograft Bioprosthesis, Porcine
- Glutaraldehyde-Stabilized Grafts
- Glutaraldehyde Stabilized Grafts
- Glutaraldehyde-Stabilized Graft
- Graft, Glutaraldehyde-Stabilized
- Grafts, Glutaraldehyde-Stabilized
Below are MeSH descriptors whose meaning is more general than "Bioprosthesis".
Below are MeSH descriptors whose meaning is more specific than "Bioprosthesis".
This graph shows the total number of publications written about "Bioprosthesis" by people in this website by year, and whether "Bioprosthesis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Bioprosthesis" by people in Profiles.
Commentary: Pulmonary valve bioprosthesis: Longevity and reintervention. J Thorac Cardiovasc Surg. 2021 02; 161(2):364-365.
Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients. JACC Cardiovasc Interv. 2020 03 23; 13(6):726-735.
Hypoplastic left heart syndrome and the allure of a valved conduit. J Thorac Cardiovasc Surg. 2018 04; 155(4):1745-1746.
Do differences in early hemodynamic performance of current generation biologic aortic valves predict outcomes 1 year following surgery? J Thorac Cardiovasc Surg. 2015 Jan; 149(1):163-73.e2.
Comparison of early hemodynamic performance of 3 aortic valve bioprostheses. J Thorac Cardiovasc Surg. 2014 Nov; 148(5):1940-6.
When repair is not feasible: prosthesis selection in children and adults with congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2014; 17(1):22-9.
A prospective, randomized comparison of 3 contemporary bioprosthetic aortic valves: should hemodynamic performance influence device selection? J Thorac Cardiovasc Surg. 2012 Dec; 144(6):1387-95, 1398; discussion 1395-7.
Establishing a swine model to compare vascular prostheses in a contaminated field. J Surg Res. 2013 May; 181(2):355-8.
Do pericardial bioprostheses improve outcome of elderly patients undergoing aortic valve replacement? Ann Thorac Surg. 2012 Jun; 93(6):1868-74; discussion 1874-5.
Does metabolic syndrome influence bioprosthetic mitral valve degeneration and reoperation rate? J Card Surg. 2012 Mar; 27(2):146-51.